Bronchial artery embolization (BAE) was performed in 22 patients with massive hemoptysis in non-malignant Lung disease. Recurrent hemosputum was noted in 10 patients after BAE. The mean period of remission of the Recurrent cases was 4.43±3.46 (Mean±SD) months. As to adverse effects, fever, back pain and bradycardia were observed immediately on BAE, but no severe side effects such as spinal injury were obserbed. There was a significant difference in the BAE findings between diffuse inflamatory lung disases and localized inflamatory lung diseases.